Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-108972
Filing Date
2025-08-14
Accepted
2025-08-14 16:31:35
Documents
71
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hura-20250630.htm   iXBRL 10-Q 2037019
2 EX-31.1 hura-ex31_1.htm EX-31.1 17546
3 EX-31.2 hura-ex31_2.htm EX-31.2 17540
4 EX-32.1 hura-ex32_1.htm EX-32.1 9958
5 EX-32.2 hura-ex32_2.htm EX-32.2 9882
  Complete submission text file 0000950170-25-108972.txt   8875955

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hura-20250630.xsd EX-101.SCH 1919121
74 EXTRACTED XBRL INSTANCE DOCUMENT hura-20250630_htm.xml XML 1209550
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37823 | Film No.: 251219961
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)